Recent Updates
Recently added Catalysts
IDYA

IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters Option to Purchase Additional Shares

Key Takeaway: IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters Option to Purchase Additional Shares
Price reaction · baseline $37.32 (2024-07-10 close) · hit after-hours · clean, no other IDYA news in the window
day 0 close
+6.2%
day 1
+7.2%
day 3 · peak
+14.3%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+47%
120-day peak, hindsight
Typical move
5.2%
average across 6 past catalysts
Cash runway
~42 mo
Minimal dilution risk
Lead asset
IDE892
Phase 1 · NSCLC Adenocarcinoma

Full Press Release Details

IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters Option to Purchase Additional Shares.
Last updated: Jul 11, 2024